Thomas Deepak, Giugliano Robert P
Brigham and Women's Hospital, Nuclear Cardiology, Boston, MA, USA.
Cardiovasc Revasc Med. 2010 Jan-Mar;11(1):41-51. doi: 10.1016/j.carrev.2009.07.005.
In 2007, the American College of Cardiology/American Heart Association and the European Society of Cardiology updated their guidelines for the management of patients with non-ST-segment elevation myocardial infarction (NSTEMI). Based on evidence from recent clinical studies, both 2007 guidelines recommend early risk stratification, administration of appropriate pharmacologic therapy, and selective use of percutaneous coronary intervention in order to reduce morbidity and mortality in these patients. In this article, we focus on management of patients with NSTEMI during the first 24 h of presentation and present a clinical scenario to illustrate the current guidelines-based management strategy.
2007年，美国心脏病学会/美国心脏协会以及欧洲心脏病学会更新了非ST段抬高型心肌梗死（NSTEMI）患者的管理指南。基于近期临床研究的证据，2007年的这两份指南均推荐进行早期风险分层、给予适当的药物治疗以及选择性地使用经皮冠状动脉介入治疗，以降低这些患者的发病率和死亡率。在本文中，我们重点关注NSTEMI患者就诊后最初24小时内的管理，并呈现一个临床病例以说明当前基于指南的管理策略。
